The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting and Board changes

13 Dec 2018 14:09

RNS Number : 4290K
Sabien Technology Group PLC
13 December 2018
 

For immediate release

13 December 2018

Sabien Technology Group plc

("Sabien" or the "Company")

Result of General Meeting

Board changes

 

Result of General Meeting

The Board of Sabien is pleased to announce that all the resolutions ("Resolutions") to approve, inter alia, the reorganisation of the Company's share capital ("Reorganisation") whereby each existing ordinary share of 0.5 pence each would be subdivided into one new ordinary share of 0.01 pence ("New Ordinary Share") and one new deferred share of 0.49 pence ("New Deferred Share"), were approved today at the Company's General Meeting.

 

As previously announced, the record date of the Reorganisation is close of business today and Admission to AIM of the New Ordinary Shares pursuant to the Reorganisation and dealings therein will therefore commence on 14 December 2018. 

 

On 23 November 2018, the Company also announced that the Company's broker, Peterhouse Capital Limited, had conditionally raised gross proceeds of £400,000 via the placing of 400,000,000 new ordinary shares in the Capital of the Company (the "Placing Shares") with new and existing investors, at a price of 0.1 pence per Placing Share. The Placing was conditional, inter alia, on the approval of the Resolutions which were approved at the General Meeting.

 

The Placing Shares will rank, pari passu, with the New Ordinary Shares. Application has been made for the Placing Shares to be admitted to trading on AIM ("Admission"), which will also become effective on 14 December 2018.

 

Following completion of the Reorganisation and Placing, the enlarged issued share capital of the Company comprises 590,254,867 New Ordinary Shares of 0.01 pence each.

 

Board Changes

Immediately following the General Meeting, Mr John Taylor has been appointed to the Board as an Interim Non-Executive Chairman. The Board anticipates making additional new Board appointments in due course. Mr Bruce Gordon has stepped down from the Board of the Company with immediate effect to focus on other business ventures. The Board would like to thank Mr Gordon for his contribution to the Company over the years would like to wish him every success in his future endeavours.

 

Further AIM disclosures relating to Mr Taylor's proposed appointment

Mr Taylor works with a group who assist small cap technology stocks with their development. Prior to that he spent eighteen months working in private equity backed portfolio companies, driving operational turnaround initiatives and implementing costing systems. He also spent over 20 years in the Army Air Corps, leaving in 2015 with the rank of colonel. Between 2013 and 2015 he was senior strategic communications officer for the Ministry of Defence. He joined the Board of Kin Group plc (subsequently renamed Bidstack Group plc) in November 2017.

 

Further disclosures on Mr Taylor as required under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies are as follows. John Edward Taylor (age 46), has held the following directorships and/or partnerships in the past five years:

 

Current:

Past:

Ugly Panda LLP

Bidstack Group plc (formerly known as Kin Group plc)

AS Group Ventures Inc

 

 

n.a.

Mr Taylor subscribed for 5,000,000 Placing Shares pursuant to the Placing. There is no further information to be disclosed in relation to Mr Taylor's appointment pursuant to AIM Rule 17 or paragraph (g) of Schedule Two of the AIM Rules for Companies.

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA"), with effect from 13 December 2018, the Company's issued share capital consists of 590,254,867 New Ordinary Shares of 0.01 pence each with voting rights. The Company does not hold any New Ordinary Shares in Treasury. Therefore, the total number of New Ordinary Shares in the Company with voting rights is 590,254,867.

 

The above figure of 590,254,867 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

--Ends--

 

For further information:

Sabien Technology Group plc

Alan O'Brien

+44(0)20 7993 3700

Beaumont Cornish Limited (Nominated Advisor)

Michael Cornish and Roland Cornish

www.beaumontcornish.com

+44(0)20 7628 3396

Peterhouse Capital Limited (Broker)

Martin Lampshire and Fungai Ndoro

+44(0)20 7469 0930

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCTJBITMBMBBAP
Date   Source Headline
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace
9th Jan 20247:00 amRNSTrading Update
29th Nov 20231:00 pmRNSResult of AGM
29th Nov 20237:30 amRNSAGM Statement
21st Nov 20231:30 pmRNSHolding(s) in Company
3rd Nov 20234:50 pmRNSHolding(s) in Company
2nd Nov 20231:34 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSFinal Results & Annual Report & Accounts for 2023
1st Nov 20237:15 amRNSUpdate on 2023 Audited Accounts
4th Oct 20237:00 amRNSM2G Rollout in US
26th Sep 20237:00 amRNSProton Technologies
22nd Sep 20236:00 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTrading Update
8th Jun 20237:00 amRNSM2G Business Update
16th May 20237:00 amRNSFurther update on b.grn and related matters
17th Apr 20237:00 amRNSUpdate on b.grn
13th Apr 20239:15 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSDirector/PCA Shareholding
5th Apr 20235:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results for the 6 months to 31 Dec 2022
28th Mar 20237:00 amRNSMaterial M2G Order & Business Update
27th Mar 20237:00 amRNSM2G supports Empiric on net zero goals
10th Mar 202311:33 amRNSHolding(s) in Company
10th Mar 202311:30 amRNSHolding(s) in Company
10th Mar 20237:00 amRNSMaterial M2G order and M2G trading update
28th Feb 20232:45 pmRNSHolding(s) in Company
6th Feb 20234:30 pmRNSHolding(s) in Company
2nd Feb 20234:51 pmRNSHolding(s) in Company
22nd Nov 202212:00 pmRNSResult of AGM
22nd Nov 20227:30 amRNSInvestor Update & Annual General Meeting Statement
18th Nov 20221:46 pmRNSHolding(s) in Company
10th Nov 20227:00 amRNSInvestor Update Presentation
2nd Nov 20227:00 amRNSSupply of UK's First Regenerative Green Oil System
24th Oct 20227:00 amRNSOrder Update – New Channel Partner & Customer
17th Oct 20222:47 pmRNSHoling(s) in Company
17th Oct 20221:54 pmRNSHolding(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trae Summit Upate
17th Oct 20227:00 amRNSHoling(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trade Summit Update
17th Oct 20227:00 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSFinal Results for the Year to 30 June 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.